Sort
261,768 grants matching “gene therapy”
Targeting leukocyte metabolism to treat human autoimmune disease
$995,802Jay L Rothstein · Immunext, Inc. · R44 · FY2020 · AI
Targeting leukocyte metabolism to treat human autoimmune disease
$995,802Jay L Rothstein · Immunext, Inc. · R44 · FY2018 · AI
Mechanisms and Optimal Combinations of Cisplatin Chemotherapy for Head and Neck Squamous Cell Carcinoma
$995,719Nicole Schmitt · National Institute On Deafness And Other Communication Disorders · ZIA · FY2019 · DC
Reprogramming of T cells for the Treatment of Melanoma
$995,664Kai W Wucherpfennig · Dana-Farber Cancer Inst · R01 · FY2014 · CA
Reprogramming of T cells for the Treatment of Melanoma
$995,664Kai W Wucherpfennig · Dana-Farber Cancer Inst · R01 · FY2016 · CA
Reprogramming of T cells for the Treatment of Melanoma
$995,664Kai W Wucherpfennig · Dana-Farber Cancer Inst · R01 · FY2015 · CA
Mechanisms of Bile Secretion and Cholestasis
$995,623James Lorenzen Boyer · Yale University · R37 · FY2017 · DK
Mechanisms of Bile Secretion and Cholestasis
$995,623James Lorenzen Boyer · Yale University · R37 · FY2015 · DK
Mechanisms of Bile Secretion and Cholestasis
$995,623James Lorenzen Boyer · Yale University · R37 · FY2016 · DK
Mechanisms of Bile Secretion and Cholestasis
$995,623James Lorenzen Boyer · Yale University · R37 · FY2013 · DK
Development of an oxygen delivery biotherapeutic for the preservation of myocardial function during pediatric cardiopulmonary bypass
$995,592Jonathan A Winger · Omniox, Inc. · R44 · FY2024 · HD
Affordable, quantitative, point-of-care microchip-electrophoresis for screening and treatment monitoring of sickle cell disease, thalassemias, and anemias
$995,495Peter Galen · Hemex Health, Inc. · R44 · FY2024 · HL
A Vaccine for Lymphatic Filariasis, LFGuardâ¢
$995,460Darrick Albert Carter · Pai Life Sciences, Inc. · R44 · FY2024 · AI
Thioredoxin Inhibitor, PX-12, in Phase II Clinical Trial
$995,448Lynn Kirkpatrick · Prolx Pharmaceuticals Corporation · R44 · FY2007 · CA
La Spada Outstanding Investigator Award
$995,408Albert R La Spada · University Of California-Irvine · R35 · FY2021 · NS
Hematopoietic stem and progenitor cell regulation for enhanced clinical efficacy
$995,319Hal E. Broxmeyer · Indiana University Indianapolis · U54 · FY2015 · DK
Motor Outcomes to Validate Evaluations in Pediatric FSHD (MOVE Peds)
$995,267Jeffrey Statland · University Of Kansas Medical Center · U01 · FY2025 · NS
Mayo Clinic Vascular Medicine Clinical Research Training Program
$995,263John A Heit · Mayo Clinic Rochester · K12 · FY2008 · HL
Multidisciplinary K12 Urologic Research Career Development Program at Baylor
$995,255Dolores Jean Lamb · Baylor College Of Medicine · K12 · FY2009 · DK
Gene expression and regulation in endocrine cancers
$995,246Electron Kebebew · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
PIXUL-FFPE: High throughput platform for chromatin and DNA sample preparation from formalin fixed paraffin embedded (FFPE) tissue samples.
$995,238Karol Bomsztyk · Matchstick Technologies, Inc. · R42 · FY2020 · HG
IMPDH-targeted antibiotics for select agents
$995,211Lizbeth K. Hedstrom · Brandeis University · R01 · FY2013 · AI
A phenotypic screen for compounds that differentially affect excitatory and inhibitory neuronal signaling
$995,203Steven John Ryan · Quiver Bioscience Inc. · R44 · FY2022 · MH
Discovery of Critical Host Genes Enabling Resistance to HIV-1 Infection as Therap
$995,189Leyla S Diaz · Functional Genetics, Inc. · R44 · FY2011 · AI
Randomized study of low versus moderate dose busulfan in transplant for severe combined immunodeficiency
$995,166Alan S. Wayne · Children'S Hospital Of Los Angeles · U01 · FY2022 · AI